Table 2.
Outcome variable | EBF terminated between 0 and 2 months (n = 567) a | EBF terminated between 2 and 4 months (n = 1223) a | EBF terminated between 4 and 6 months (n = 1918) a | PAF % | |||
---|---|---|---|---|---|---|---|
Crude OR (95% CI) | Adjusted OR (95% CI) | Crude OR (95% CI) | Adjusted OR (95% CI) | Crude OR (95% CI) | Adjusted OR (95% CI) | ||
Diarrhea | 5.80 (3.19–11.63) | 4.94 (3.17–10.23) | 3.13 (2.04–4.87) | 3.07 (2.11–5.03) | 2.34 (1.89–3.11) | 2.30 (1.89–3.20) | 27.37 |
Fever | 2.24 (2.00–2.98) | 2.18 (1.56–3.04) | 1.54 (1.35–1.78) | 1.53 (1.37–2.10) | 1.25 (1.07–1.48) | 1.23 (1.06–1.63) | 13.24 |
ARI | 2.43 (1.98–3.45) | 2.38 (1.27–3.26) | 1.42 (1.13–1.75) | 1.40 (1.10–1.76) | 1.25 (1.03–1.48) | 1.19 (1.04–1.57) | 8.94 |
At least one of the above three diseases | 2.56 (2.12–3.38) | 2.50 (2.10–3.32) | 1.63 (1.40–1.95) | 1.64 (1.30–1.98) | 1.45 (1.22–1.79) | 1.42 (1.20–1.76) | 10.52 |
aReference group: EBF not terminated up to six months
Note: n: total sample size, OR odds ratio, CI confidence interval, PAF population-attributable fraction (if EBF was not discontinued during first six months)